pET-32b(+)质粒载体图谱序列抗性
产品名称: pET-32b(+)质粒载体图谱序列抗性
英文名称: pET-32b(+)质粒载体图谱序列抗性说明书
产品编号: 39589853061
产品价格: 0
产品产地: Biovector Inc. USA
品牌商标: Biovector中国质粒载体菌株细胞
更新时间: null
使用范围: null
IV style="POSITION: relative; TEXT-ALIGN: left; PADDING-BOTTOM: 0px; TEXT-TRANSFORM: none; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; MARGIN: 0px 0px 16px; PADDING-LEFT: 0px; LETTER-SPACING: normal; PADDING-RIGHT: 0px; FONT: 14px Verdana, Arial, Tahoma; MAX-WIDTH: 620px; WHITE-SPACE: normal; COLOR: rgb(51,51,51); WORD-SPACING: 0px; PADDING-TOP: 0px; -webkit-text-stroke-width: 0px" class=main-title>pET32b载体基本信息
出品公司:别名:质粒类型:表达水平:克隆方法:载体大小:5 测序引物:5 测序引物序列: 载体标签:载体抗性:备注:产品目录号:稳定性:组成型:病毒/非病毒:
EMD Biosciences(Novagen) pET32b, pet 32b 大肠杆菌蛋白表达 高 多克隆位点,限制性内切酶 5899bp T7或者Trx-F T7: 5-TAATACGACTCACTATAGGG-3; Trx-F: 5 TTCCTCGACGCTAACCTG 3 thioredoxin (N端); His (中间和C端) Ampicillin Production of soluble, active target proteins; N-term thrombin cleavage site;
Nterm enterokinase cleavage site; a,b,c vary by MCS69016-3 瞬时表达 Transient 组成型 Constitutive 非病毒 pET32b载体质粒图谱和多克隆位点信息
pET32b载体简介
The pET-32a-c series is designed for cloning and high-level expression of peptide sequences fused with the 109aa Trx•Tag™ thioredoxin protein (1). Cloning sites are available for producing fusion proteins also containing cleavable His•Tag® and S•Tag™ sequences for detection and purification. Unique sites are shown on the circle map. Note that the sequence is numbered by the pBR322 convention, so the T7 expression region is reversed on the circle map. The cloning/expression region of the coding strand transcribed by T7 RNA polymerase is shown below. The f1 origin is oriented so that infection with helper phage will produce virions containing single-stranded DNA that corresponds to the coding strand. Therefore, single-stranded sequencing should be performed using the T7 terminator primer (Cat. No. 69337-3).
pET32b载体序列
LOCUS pET-32b(+) 5899 bp DNA circular 11-SEP-2008
SOURCE
ORGANISM
COMMENT This file is created by Vector NTI
http://www.biofeng.com/
COMMENT ORIGDB|GenBank
COMMENT VNTAUTHORNAME|biofeng.com|
COMMENT VNTOAUTHORAD1|Novagen Inc.|
FEATURES Location/Qualifiers
promoter complement(763..779)
/vntifkey="30"
/label=T7\promoter
misc_signal complement(365..691)
/vntifkey="87"
/label=trx\tag
protein_bind complement(326..343)
/vntifkey="31"
/label=His\tag
misc_feature complement(248..292)
/vntifkey="21"
/label=S\tag
protein_bind complement(140..157)
/vntifkey="31"
/label=His\tag
terminator complement(26..72)
/vntifkey="43"
/label=T7\terminator
CDS 1170..2249
/vntifkey="4"
/label=lac\I
rep_origin complement(3683..3683)
/vntifkey="33"
/label=ColE1\pBR322\origin
CDS complement(736..760)
/vntifkey="4"
/label=lac\operator
protein_bind complement(299..316)
/vntifkey="31"
/label=thrombin
protein_bind complement(218..232)
/vntifkey="31"
/label=enterokinase
CDS complement(4444..5301)
/vntifkey="4"
/label=bla\(amp)\sequence
rep_origin complement(5433..5888)
/vntifkey="33"
/label=f1\origin
BASE COUNT 1390 a 1564 c 1560 g 1385 t
ORIGIN
1 atccggatat agttcctcct ttcagcaaaa aacccctcaa gacccgttta gaggccccaa
61 ggggttatgc tagttattgc tcagcggtgg cagcagccaa ctcagcttcc tttcgggctt
121 tgttagcagc cggatctcag tggtggtggt ggtggtgctc gagtgcggcc gcaagcttgt
181 cgacggagct cgaattcgga tccgatatcg ccatggcctt gtcgtcgtcg tcggtaccca
241 gatctgggct gtccatgtgc tggcgttcga atttagcagc agcggtttct ttcataccag
301 aaccgcgtgg caccagacca gaagaatgat gatgatgatg gtgcatatgg ccagaaccag
361 aaccggccag gttagcgtcg aggaactctt tcaactgacc tttagacagt gcacccactt
421 tggttgccgc cacttcaccg tttttgaaca gcagcagagt cgggatacca cggatgccat
481 atttcggcgc agtgccaggg ttttgatcga tgttcagttt tgcaacggtc agtttgccct
541 gatattcgtc agcgatttca tccagaatcg gggcgatcat tttgcacgga ccgcaccact
601 ctgcccagaa atcgacgagg atcgccccgt ccgctttgag tacatccgtg tcaaaactgt
661 cgtcagtcag gtgaataatt ttatcgctca tatgtatatc tccttcttaa agttaaacaa
721 aattatttct agaggggaat tgttatccgc tcacaattcc cctatagtga gtcgtattaa
781 tttcgcggga tcgagatcga tctcgatcct ctacgccgga cgcatcgtgg ccggcatcac
841 cggcgccaca ggtgcggttg ctggcgccta tatcgccgac atcaccgatg gggaagatcg
901 ggctcgccac ttcgggctca tgagcgcttg tttcggcgtg ggtatggtgg caggccccgt
961 ggccggggga ctgttgggcg ccatctcctt gcatgcacca ttccttgcgg cggcggtgct
1021 caacggcctc aacctactac tgggctgctt cctaatgcag gagtcgcata agggagagcg
1081 tcgagatccc ggacaccatc gaatggcgca aaacctttcg cggtatggca tgatagcgcc
1141 cggaagagag tcaattcagg gtggtgaatg tgaaaccagt aacgttatac gatgtcgcag
1201 agtatgccgg tgtctcttat cagaccgttt cccgcgtggt gaaccaggcc agccacgttt
1261 ctgcgaaaac gcgggaaaaa gtggaagcgg cgatggcgga gctgaattac attcccaacc
1321 gcgtggcaca acaactggcg ggcaaacagt cgttgctgat tggcgttgcc acctccagtc
1381 tggccctgca cgcgccgtcg caaattgtcg cggcgattaa atctcgcgcc gatcaactgg
1441 gtgccagcgt ggtggtgtcg atggtagaac gaagcggcgt cgaagcctgt aaagcggcgg
1501 tgcacaatct tctcgcgcaa cgcgtcagtg ggctgatcat taactatccg ctggatgacc
1561 aggatgccat tgctgtggaa gctgcctgca ctaatgttcc ggcgttattt cttgatgtct
1621 ctgaccagac acccatcaac agtattattt tctcccatga agacggtacg cgactgggcg
1681 tggagcatct ggtcgcattg ggtcaccagc aaatcgcgct gttagcgggc ccattaagtt
1741 ctgtctcggc gcgtctgcgt ctggctggct ggcataaata tctcactcgc aatcaaattc
1801 agccgatagc ggaacgggaa ggcgactgga gtgccatgtc cggttttcaa caaaccatgc
1861 aaatgctgaa tgagggcatc gttcccactg cgatgctggt tgccaacgat cagatggcgc